Edwards Lifesciences Announces Appointment of Chief Financial Officer

Theodora Mistras join's Edwards Lifesciences from Viatris Inc., where she has been Chief Financial Officer (CFO) since March 2024 leading global finance operations including planning, reporting and overall financial management across the business.

Before Viatris, she was a managing director in healthcare investment banking at Citigroup Global Markets and previously held senior roles at Goldman Sachs, bringing decades of experience advising companies on finance, strategy and investor relations. She holds degrees from the University of Pennsylvania and the Wharton School.

“We are very pleased to welcome Doretta to Edwards as our next CFO,” said Bernard Zovighian, Edwards’ CEO. “Doretta’s broad experience will be instrumental as we execute our differentiated strategy. We look forward to her leadership as we continue to invest in innovation, and also deliver distinguished and durable financial results and long-term value to patients, customers, shareholders and the broader healthcare ecosystem.”

Read More:Viatris Announces CFO Transition and Leadership Change

Ullem has served as Edwards’ CFO since 2014. “We would like to once again thank Scott for his outstanding leadership, partnership and impact,” Zovighian added. “His commitment to a thoughtful transition and his continued support as a strategic advisor in the months ahead reflect the discipline and continuity that have long defined Edwards’ approach to leadership. We are grateful for Scott’s numerous contributions over the years that have helped to strengthen our company both strategically and financially.”

About Edwards Lifesciences

Founded in 1958 Edwards Lifesciences is a global leader in structural heart innovation focused on improving patient lives through advanced medical technologies, strong clinical evidence and partnerships with healthcare professionals. The company serves patients in over 100 countries, with a workforce spanning research and development, clinical affairs, regulatory, quality, and sales, all driven by a patient-centered approach.

Read More:General Proximity Receives Investment from FreeMind Group